Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cotter, MA; Mirrlees, DJ; Cameron, NE
   Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   M.A. Cotter et al., "Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats", EUR J PHARM, 417(3), 2001, pp. 223-230
2. Brown, GR; Hollinshead, DM; Stokes, ESE; Waterson, D; Clarke, DS; Foubister, AJ; Glossop, SC; McTaggart, F; Mirrlees, DJ; Smith, GJ; Wood, R
   A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase
   JOURNAL OF MEDICINAL CHEMISTRY
   
   G.R. Brown et al., "A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase", J MED CHEM, 43(26), 2000, pp. 4964-4972
3. Brown, GR; Hollinshead, DM; Stokes, ESE; Clarke, DS; Eakin, MA; Foubister, AJ; Glossop, SG; Griffiths, D; Johnson, MC; McTaggart, F; Mirrlees, DJ; Smith, GJ; Wood, R
   Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: Optimization from lipid profiles
   JOURNAL OF MEDICINAL CHEMISTRY
   
   G.R. Brown et al., "Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: Optimization from lipid profiles", J MED CHEM, 42(7), 1999, pp. 1306-1311
4. BROWN GR; FOUBISTER AJ; FREEMAN S; MCTAGGART F; MIRRLEES DJ; REID AC; SMITH GJ; TAYLOR MJ; THOMASON DA; WHITTAMORE PRO
   NOVEL OPTIMIZED QUINUCLIDINE SQUALENE SYNTHASE INHIBITORS
   Bioorganic & medicinal chemistry letters
   
   G.R. Brown et al., "NOVEL OPTIMIZED QUINUCLIDINE SQUALENE SYNTHASE INHIBITORS", Bioorganic & medicinal chemistry letters, 7(5), 1997, pp. 597-600
5. MCTAGGART F; BROWN GR; DAVIDSON RG; FREEMAN S; HOLDGATE GA; MALLION KB; MIRRLEES DJ; SMITH GJ; WARD WHJ
   INHIBITION OF SQUALENE SYNTHASE OF RAT-LIVER BY NOVEL 3'-SUBSTITUTED QUINUCLIDINES
   Biochemical pharmacology
   
   F. Mctaggart et al., "INHIBITION OF SQUALENE SYNTHASE OF RAT-LIVER BY NOVEL 3'-SUBSTITUTED QUINUCLIDINES", Biochemical pharmacology, 51(11), 1996, pp. 1477-1487
6. WATERTON JC; BREEN SA; MIRRLEES DJ; SENNITT CM; CAREY F
   INHIBITION OF ALDOSE REDUCTASE - C-13 NMR-STUDIES IN ISOLATED PERIPHERAL-NERVE
   NMR in biomedicine
   
   J.C. Waterton et al., "INHIBITION OF ALDOSE REDUCTASE - C-13 NMR-STUDIES IN ISOLATED PERIPHERAL-NERVE", NMR in biomedicine, 8(3), 1995, pp. 133-138
7. COOK PN; WARD WHJ; PETRASH JM; MIRRLEES DJ; SENNITT CM; CAREY F; PRESTON J; BRITTAIN DR; TUFFIN DP; HOWE R
   KINETIC CHARACTERISTICS OF ZENECA ZD5522, A POTENT INHIBITOR OF HUMANAND BOVINE LENS ALDOSE REDUCTASE
   Biochemical pharmacology
   
   P.N. Cook et al., "KINETIC CHARACTERISTICS OF ZENECA ZD5522, A POTENT INHIBITOR OF HUMANAND BOVINE LENS ALDOSE REDUCTASE", Biochemical pharmacology, 49(8), 1995, pp. 1043-1049
8. CAMERON NE; COTTER MA; DINES KC; MAXFIELD EK; CAREY F; MIRRLEES DJ
   ALDOSE REDUCTASE INHIBITION, NERVE PERFUSION, OXYGENATION AND FUNCTION IN STREPTOZOTOCIN-DIABETIC RATS - DOSE-RESPONSE CONSIDERATIONS AND INDEPENDENCE FROM A MYOINOSITOL MECHANISM
   Diabetologia
   
   N.E. Cameron et al., "ALDOSE REDUCTASE INHIBITION, NERVE PERFUSION, OXYGENATION AND FUNCTION IN STREPTOZOTOCIN-DIABETIC RATS - DOSE-RESPONSE CONSIDERATIONS AND INDEPENDENCE FROM A MYOINOSITOL MECHANISM", Diabetologia, 37(7), 1994, pp. 651-663
9. CAREY F; MIRRLEES DJ; SENNITT C; TUFFIN DP; WARD WH; BRITTAIN DR; HOWE R; PRESTON J
   BIOCHEMICAL PHARMACOLOGY IN THE RAT OF THE NOVEL ALDOSE REDUCTASE INHIBITOR ZD5522
   British Journal of Pharmacology
   
   F. Carey et al., "BIOCHEMICAL PHARMACOLOGY IN THE RAT OF THE NOVEL ALDOSE REDUCTASE INHIBITOR ZD5522", British Journal of Pharmacology, 112, 1994, pp. 210000040-210000040
10. TAYLOR PD; WICKENDEN AD; MIRRLEES DJ; POSTON L
    ENDOTHELIAL FUNCTION IN THE ISOLATED-PERFUSED MESENTERY AND AORTAE OFRATS WITH STREPTOZOTOCIN-INDUCED DIABETES - EFFECT OF TREATMENT WITH THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT
    British Journal of Pharmacology
    
    P.D. Taylor et al., "ENDOTHELIAL FUNCTION IN THE ISOLATED-PERFUSED MESENTERY AND AORTAE OFRATS WITH STREPTOZOTOCIN-INDUCED DIABETES - EFFECT OF TREATMENT WITH THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT", British Journal of Pharmacology, 111(1), 1994, pp. 42-48